Skip to main content
Log in

Multi-modality management for loco-regionally advanced laryngeal and hypopharyngeal cancer: balancing the benefit of efficacy and functional preservation

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The 5-year overall survival (OS) of loco-regionally advanced laryngeal and hypopharyngeal carcinoma (LA-LHC) has declined over the past two decades following the wide application of non-surgical approaches. We aimed to define the new role of open surgery combined with adjuvant chemoradiotherapy in the treatment of LA-LHC for improving survival while maintaining a functional larynx. In the current study, 90 LA-LHC patients treated with open surgery followed by postoperative RT/CRT in our institute from May 2005 to December 2012 were retrospectively analyzed. OS, disease-free survival (DFS), loco-regional failure-free survival (LRFFS) and distant metastasis-free survival (DMFS) were calculated, and prognostic factors were analyzed. Functional larynx preservation results were evaluated according to the head and neck quality of life (QoL) Scale. With a median follow-up period of 37 months, the 3- and 5-year OS, DFS, LRFFS and DMFS were 71.3, 63.7, 85.9, 73.7 and 55.9, 53.0, 81.6, 71.9 %, respectively. Vascular embolism and extracapsular extension (ECE) of the lymph nodes were prognostic factors for poorer OS (p = 0.045 and 0.046, respectively). Vascular embolism was the only prognostic factor for poorer DMFS (p = 0.005). Patients who underwent a conservative partial laryngectomy (CPL) experienced a higher QoL in the domains of speech, swallowing and emotion. Functional larynx preservation was achieved in 36/45 patients (80 %) who received CPL. The results of our study demonstrated that CPL followed by adequate adjuvant therapy could achieve superior oncological results compared with non-surgical approaches in LA-LHC patients while also maintaining satisfactory functional larynx in a majority of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.

    Article  PubMed  CAS  Google Scholar 

  2. Cooper JS, Porter K, Mallin K, et al. National cancer database report on cancer of the head and neck: 10-year update. Head Neck. 2009;31(6):748–58.

    Article  PubMed  Google Scholar 

  3. National Comprehensive Cancer Network. Clinical practice guidelines in head and neck cancers. 2014. www.nccn.org. Accessed 30 May 2014.

  4. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685–90.

    Article  Google Scholar 

  5. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III Trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996;88(13):890–9.

    Article  PubMed  CAS  Google Scholar 

  6. Lefebvre JL, Andry G, Chevalier D, et al. Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. Ann Oncol. 2012;23(10):2708–14.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–8.

    Article  PubMed  CAS  Google Scholar 

  8. Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31(7):845–52.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. Ca-Cancer J Clin. 2014;64(1):9–29.

    Article  PubMed  Google Scholar 

  10. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006;116111(92):1–13.

    Article  Google Scholar 

  11. SEER Cancer Statistics Review, 1975–2010. 2013. http://seer.cancer.gov/csr/1975_2010/. Accessed April 2013.

  12. Pfister DG, Laurie SA, Weinstein GS, et al. American society of clinical oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol. 2006;24(22):3693–704.

    Article  PubMed  Google Scholar 

  13. Richard JM, Sancho-Garnier H, Pessey JJ, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol. 1998;34(3):224–8.

    Article  PubMed  CAS  Google Scholar 

  14. Takes RP, Strojan P, Silver CE, et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck. 2012;34(2):270–81.

    Article  PubMed  Google Scholar 

  15. Wang YL, Feng SH, Zhu J, et al. Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: a population-based analysis. PLoS ONE. 2013;8(2):e56613.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Genden EM, Ferlito A, Rinaldo A, et al. Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck J Sci Spec. 2008;30(1):103–10.

    Article  Google Scholar 

  17. Terrell JE, Nanavati KA, Esclamado RM, Bishop JK, Bradford CR, Wolf GT. Head and neck cancer-specific quality of life—instrument validation. Arch Otolaryngol. 1997;123(10):1125–32.

    Article  CAS  Google Scholar 

  18. Ware JE. SF-36 health survey: manual and interpretation guide, Boston: Health Institute; 1993.

  19. Lefebvre JL, Rolland F, Tesselaar M, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer I. 2009;101(3):142–52.

    Article  CAS  Google Scholar 

  20. Calais G, Pointreau Y, Alfonsi M, Sire C, Tuchais C, Tortochaux J, Guerif S. Induction chemotherapy for larynx preservation. updated results of the GORTEC 2000-01 randomized trial comparing docetaxel plus cisplatinum plus fluorouracil (TPF) versus cisplatinum plus fluorouracil (PF). EJC Suppl. 2007;5(4):324.

    Article  Google Scholar 

  21. Posner MR, Norris CM, Wirth LJ, et al. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol. 2009;20(5):921–7.

    Article  PubMed  CAS  Google Scholar 

  22. Lefebvre JL, Pointreau Y, Rolland F, et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II Study. J Clin Oncol. 2013;31(7):853–9.

    Article  PubMed  CAS  Google Scholar 

  23. Dufour X, Hans S, De Mones E, Brasnu D, Menard M, Laccourreye O. Local control after supracricoid partial laryngectomy for “advanced” endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg. 2004;130(9):1092–9.

    Article  PubMed  Google Scholar 

  24. Pinar E, Imre A, Calli C, Oncel S, Katilmis H. Supracricoid partial laryngectomy: analyses of oncologic and functional outcomes. Otolaryngol Head Neck Surg. 2012;147(6):1093–8.

    Article  PubMed  Google Scholar 

  25. Laccourreye O, Muscatello L, Laccourreye L, Naudo P, Brasnu D, Weinstein G. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for “early” glottic carcinoma classified as T1-T2N0 invading the anterior commissure. Am J Otolaryngol. 1997;18(6):385–90.

    Article  PubMed  CAS  Google Scholar 

  26. Bron L, Brossard E, Monnier P, Pasche P. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas. Laryngoscope. 2000;110(4):627–34.

    Article  PubMed  CAS  Google Scholar 

  27. Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet JJ. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol. 1997;106(5):364–9.

    Article  PubMed  CAS  Google Scholar 

  28. Boscolo-Rizzo P, Maronato F, Marchiori C, Gava A, Da Mosto MC. Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope. 2008;118(2):300–6.

    Article  PubMed  Google Scholar 

  29. Bien S, Okla S, van As-Brooks CJ, Ackerstaff AH. The effect of a heat and moisture exchanger (Provox(A (R)) HME) on pulmonary protection after total laryngectomy: a randomized controlled study. Eur Arch Oto-Rhino-L. 2010;267(3):429–35.

    Article  Google Scholar 

  30. Herranz J, Alvarez Espino M, Ogen Morado C. Pulmonary rehabilitation after total laryngectomy: a randomized cross-over clinical trial comparing two different heat and moisture exchangers (HMEs). Eur Arch Oto Rhino L. 2013; 270(9): 2479–84.

  31. Wei W, Zhang N. Temporal correlation and multivariate analysis quality of life after laryngectomy. 2011 eleventh international and national head and neck academic conference. Hangzhou, Zhejiang Province, China: 2011:7.

  32. Lefebvre JL, Ang KK. Larynx preservation clinical trial design: key issues and recommendations-A consensus panel summary. Int J Radiat Oncol Biol Phys. 2009;73(5):1293–303.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guopei Zhu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qian, W., Zhu, G., Wang, Y. et al. Multi-modality management for loco-regionally advanced laryngeal and hypopharyngeal cancer: balancing the benefit of efficacy and functional preservation. Med Oncol 31, 178 (2014). https://doi.org/10.1007/s12032-014-0178-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0178-2

Keywords

Navigation